Unraveling the Genetic Basis for OSA
An international consortium spanning five continents is working together to unravel the genetic basis for obstructive sleep apnea.
Read MoreAn international consortium spanning five continents is working together to unravel the genetic basis for obstructive sleep apnea.
Read MoreUsing light, researchers at Stanford and the University of Mainz could both stimulate slow waves and observe them in unprecedented detail.
Read MoreManaged Services Program automates patient management and enhances revenue opportunities for HME providers.
Read MoreGalleon’s drugs work through a novel mechanism of action allowing creation of both oral and intravenous products for a variety of clinical uses including: post-surgical care of high-risk patients, chronic pain patients using opioids, and sleep apnea.
Read MoreVentus Medical, maker of Provent Sleep Apnea Therapy, is going out of business, but a group of new investors has purchased the assets of the company and are committed to continuing to make Provent and Theravent available.
Read More